Regeneron Pharmaceuticals, Inc. (LON:0R2M)
605.14
+5.74 (0.96%)
At close: Oct 3, 2025
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,106 employees as of December 31, 2024. The number of employees increased by 1,656 or 12.31% compared to the previous year.
Employees
15,106
Change (1Y)
1,656
Growth (1Y)
12.31%
Revenue / Employee
683.37K GBP
Profits / Employee
214.35K GBP
Market Cap
46.16B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Regeneron Pharmaceuticals News
- 3 days ago - Formycon Reaches Settlement With Regeneron Over U.S. Eylea Biosimilar Patent Disputes - Nasdaq
- 4 days ago - Notable Wednesday Option Activity: CVS, HOOD, REGN - Nasdaq
- 4 days ago - Wednesday's ETF Movers: FBT, BIZD - Nasdaq
- 4 days ago - Regeneron (REGN) Sees Stock Surge as Core Product Sales Rise - GuruFocus
- 4 days ago - REGN Makes Bullish Cross Above Critical Moving Average - Nasdaq
- 5 days ago - Regeneron: Growth Catalysts Incoming - Seeking Alpha
- 5 days ago - Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025 - GlobeNewsWire
- 5 days ago - Final Trades: Nvidia, Amphenol, Regeneron and Lockheed Martin - CNBC